Utilization of a 3D Bioprinted Liver Tissue Model to Evaluate the Antifibrotic Effects of an ALK5 Inhibitor in a TGFβ-induced Model of Hepatic Fibrosis

Liver Model, Presented at Society of Toxicology Annual Meeting, San Antonio, Texas, March 2018.